How donations are spent

In 2023/24 we supported 28 million treatments reaching 19 million people at risk from parasitic disease in eight countries.

Our programme partners are doing an amazing job, and there are still more countries that need support. With more funding, we’re confident we can help reach even more people.

How donations were spent in 2023-24

Transfers to partners

In 2023-24, we transferred £5.3 million to our partners and provided technical expertise to support their work in the treatment and elimination of parasitic disease.

Côte d’Ivoire: £1,950,000
Democratic Republic of the Congo (DRC): £687,000
Malawi: £663,000
Tanzania: £632,000
Kenya: £505,000
Uganda: £330,000
Ethiopia: £290,000
Mauritania: £150,000
Madagascar: £145,000
Burundi: £35,000

Our expenditure

Supporting treatment for parasitic worm disease

In 2024/25 we aim to continue to support treatment for millions of people in endemic countries, including broadening access to treatment for people who currently don’t receive it, for example preschool children and women of reproductive age.

So at a cost of around 0.33p per person treated, your donation, however small, can make a real impact on people’s health, education and quality of life.

£50 can ensure that 150 people have access to deworming treatment and can live lives unlimited by preventable parasitic disease.

Tackling the drivers of infection

Even expanding access to treatment for people who currently miss out will not be enough on its own to achieve elimination of parasitic worm disease. To address this, we have been working on other key drivers of parasitic disease, such as unsafe water contact and transmission between animals and humans.

£42 could keep people safe from contaminated water while they earn their living from fishing.**

Donate now

“I started feeling uncomfortable and had pain. I stopped going to the lake because I was not feeling well. Before receiving the treatment, I was really unhappy. But now I am happy and can play games to the end.” – Said from Zanzibar. Image by: Unlimit Health/William Mgobelo

Getting treatment to more people at risk

Only 30% of people needing treatment globally for schistosomiasis were treated in 2021.*

176.1 million people at risk from parasitic disease did not receive treatment, in part as a result of continuing difficulties caused by the Covid-19 pandemic.

We are now working hard with our country partners to close this treatment gap. This includes broadening access to treatment to include groups not adequately covered by mass treatment campaigns, such as pre-school children and women of reproductive age.